BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Industry tailwinds. Operates in a specialized market. Expanding profit margins.Strong organic and inorganic growth.Unlock Premium - Try 5i Free

Healthcare
BUY on WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Industry tailwinds. Operates in a specialized market. Expanding profit margins. Strong organic and inorganic growth.
Healthcare
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Industry tailwinds. Operates in a specialized market. Expanding profit margins. Strong organic and inorganic growth.
Healthcare
BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Industry tailwinds. Operates in a specialized market. Expanding profit margins. Strong organic and inorganic growth.
Healthcare
TOP PICK
Healthcare logistics. Deliver time- and temperature-sensitive pharmaceuticals. Leader in Canada, unique business. Great partnerships. Expanded facilities. Recent acquisition gives them a foothold in Canada-US delivery. Yield is 0.43%. (Analysts’ price target is $46.83)
Healthcare
BUY

AND does drug distribution in western Canada. Incredibly stable business with good runway for growth. Nice compliment to a portfolio without expensive or risky plays. DNTL rolls up dental practices in Canada. A recession proof business.

Healthcare
DON'T BUY
It's in the right space to benefit from Covid. But a number of things have to go right. Need a vaccine approved, and it has to be refrigerated. Strong price momentum, but expensive.
Healthcare
TOP PICK
It's a recent IPO. It's a really a three-party transportation logistics company, shipping chemicals and pharmaceuticals for the healthcare industry. As a result, they have higher margins. Managers have a lot of experience in this business and hold lots of stock. Trades at a reasonable multiple. They should deliver better than expected earnings and a multiples bump in coming years. (Analysts’ price target is $22.83)
Healthcare
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Andlauer Healthcare Group(AND-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Andlauer Healthcare Group is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Andlauer Healthcare Group(AND-T) Frequently Asked Questions

What is Andlauer Healthcare Group stock symbol?

Andlauer Healthcare Group is a Canadian stock, trading under the symbol AND-T on the Toronto Stock Exchange (AND-CT). It is usually referred to as TSX:AND or AND-T

Is Andlauer Healthcare Group a buy or a sell?

In the last year, 4 stock analysts published opinions about AND-T. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Andlauer Healthcare Group.

Is Andlauer Healthcare Group a good investment or a top pick?

Andlauer Healthcare Group was recommended as a Top Pick by on . Read the latest stock experts ratings for Andlauer Healthcare Group.

Why is Andlauer Healthcare Group stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Andlauer Healthcare Group worth watching?

4 stock analysts on Stockchase covered Andlauer Healthcare Group In the last year. It is a trending stock that is worth watching.

What is Andlauer Healthcare Group stock price?

On 2023-03-17, Andlauer Healthcare Group (AND-T) stock closed at a price of $45.67.